Literature DB >> 31972450

Oxalates, urinary stones and risk of cardiovascular diseases.

Ahmed Arafa1, Ehab S Eshak2, Hiroyasu Iso3.   

Abstract

Increased level of oxalates in urine and plasma can be attributed to endogenous overproduction, increased ingestion or excessive intestinal absorption. When a supersaturation status is reached, oxalates combine with calcium and crystallize to form 80% of the urinary stones. Several cardiovascular diseases such as coronary heart disease and stroke are thought to be associated with the formation of urinary stones via sharing the same pathogenesis and/or risk factors. This review investigated the evidence linking oxalates/urinary stones to cardiovascular diseases. Eventually, two theories can explain the possible association between urinary stones and cardiovascular diseases: the theory of common origin and the theory of common risk factors. While the first theory is based on the common vascular pathophysiology of urinary stones and cardiac events, the later suggests that metabolic syndrome traits increase the risk of urinary stones and cardiovascular diseases independently. A few cohort studies showed a higher risk of coronary heart disease and stroke among people with history of urinary stones than people without it while other cohort studies did not. These studies had different definitions for cardiovascular diseases, used various methods to assess urinary stones, and some of them did not control for potential confounders. When they were pooled together in meta-analyses, a significant heterogeneity across studies was observed. In conclusion, although there is some evidence indicating that urinary stones could increase the risk of cardiovascular diseases, a substantial causal relationship cannot be settled.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Cardiovascular diseases; Coronary heart disease; Oxalates; Stroke; Urinary stones

Mesh:

Substances:

Year:  2020        PMID: 31972450     DOI: 10.1016/j.mehy.2020.109570

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  Oxalate Balance in Peritoneal Dialysis Patients: A Potential Role of Dialysis-related Peritonitis.

Authors:  Natalia Stepanova; Lesya Korol; Larysa Lebid; Lyudmyla Snisar; Svitlana Savchenko
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Urinary Stones and Risk of Coronary Heart Disease and Stroke: the Japan Public Health Center-Based Prospective Study.

Authors:  Ahmed Arafa; Ehab S Eshak; Hiroyasu Iso; Kokoro Shirai; Isao Muraki; Norie Sawada; Shoichiro Tsugane
Journal:  J Atheroscler Thromb       Date:  2020-06-05       Impact factor: 4.928

3.  Dietary oxalate to calcium ratio and incident cardiovascular events: a 10-year follow-up among an Asian population.

Authors:  Zahra Bahadoran; Parvin Mirmiran; Fereidoun Azizi
Journal:  Nutr J       Date:  2022-03-28       Impact factor: 3.271

4.  Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.

Authors:  Yuhao Liu; Ying Zhao; Yousef Shukha; Haocheng Lu; Lu Wang; Zhipeng Liu; Cai Liu; Yang Zhao; Huilun Wang; Guizhen Zhao; Wenying Liang; Yanbo Fan; Lin Chang; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr; Michael Aviram; Bo Wen; Minerva T Garcia-Barrio; Jifeng Zhang; Wanqing Liu; Duxin Sun; Tony Hayek; Y Eugene Chen; Oren Rom
Journal:  Cell Rep       Date:  2021-07-27       Impact factor: 9.423

5.  Fabrication of the macro and micro-scale microbial fuel cells to monitor oxalate biodegradation in human urine.

Authors:  Reyhaneh Yousefi; Mohammad Mahdi Mardanpour; Soheila Yaghmaei
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

6.  Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study.

Authors:  Natalia Stepanova; Victoria Driianska; Lesya Korol; Lyudmyla Snisar; Larysa Lebed
Journal:  Korean J Intern Med       Date:  2021-06-25       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.